NYSEMKT: VNRX
Volitionrx Ltd Stock Forecast, Predictions & Price Target

Analyst price target for VNRX

Based on 3 analysts offering 12 month price targets for Volitionrx Ltd

Min Forecast
$2.50+252.11%
Avg Forecast
$3.50+392.96%
Max Forecast
$5.00+604.23%

Should I buy or sell VNRX stock?

Based on 3 analysts offering ratings for Volitionrx Ltd.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VNRX stock forecasts and price targets.

VNRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-10
lockedlocked$00.00+00.00%2025-04-30
lockedlocked$00.00+00.00%2025-04-11

1 of 1

VNRX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
VNRX$0.71$3.50+392.96%Strong Buy
NOTV$2.12$5.00+135.85%Strong Buy
IMDX$2.91$5.42+86.15%Buy
SERA$2.72N/AN/A
FONR$15.59N/AN/A

Volitionrx Stock Forecast FAQ

Is Volitionrx Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSEMKT: VNRX) stock is to Strong Buy VNRX stock.

Out of 3 analysts, 2 (66.67%) are recommending VNRX as a Strong Buy, 1 (33.33%) are recommending VNRX as a Buy, 0 (0%) are recommending VNRX as a Hold, 0 (0%) are recommending VNRX as a Sell, and 0 (0%) are recommending VNRX as a Strong Sell.

If you're new to stock investing, here's how to buy Volitionrx stock.

What is VNRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VNRX price target, the average VNRX price target is $3.50, with the highest VNRX stock price forecast at $5.00 and the lowest VNRX stock price forecast at $2.50.

On average, Wall Street analysts predict that Volitionrx's share price could reach $3.50 by Jun 10, 2026. The average Volitionrx stock price prediction forecasts a potential upside of 392.96% from the current VNRX share price of $0.71.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.